SCHEMBL9539990

SCHEMBL9539990

Cn1c(-c2ccccc2)c2ccccc2nc1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 5/20 0.49
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
MAPT P10636 2/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM4C Q9H3R0 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
TERT O14746 1/20 0.44
CASP3 P42574 1/20 0.44
LMNA P02545 1/20 0.44
TNKS O95271 1/20 0.43
PARP1 P09874 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
ELANE P08246 1/20 0.43
TLR7 Q9NYK1 1/20 0.43
TDP2 O95551 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9540062 0.82 KDM4E (0.51) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL9540027 0.82 MEN1 (0.51) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL9539883 0.82 MEN1 (0.47) KDM4EALDH1A1HPGDKMT2ALMNA
SCHEMBL11865898 0.80 ADORA2A (0.44) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL7905247 0.75 ALDH1A1 (0.50) KDM4EALDH1A1HPGDMAPTCYP2C19
SCHEMBL9539800 0.73 FABP3 (0.46) KDM4EALDH1A1MAPTKDM4CCASP3
SCHEMBL1463333 0.73 KMT2A (0.65) KDM4EALDH1A1MAPTKMT2ANPC1
SCHEMBL29764078 0.73 KMT2A (0.65) KDM4EALDH1A1MAPTKMT2ANPC1
SCHEMBL11608488 0.71 HPGD (0.53) KDM4EALDH1A1GAAHPGDCYP2C19
SCHEMBL2834048 0.70 GABRA1 (0.44) KDM4EALDH1A1GAAHPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1071917-A Quinazoline derivant as human immunodeficiency virus reversed transcriptive enzyme antagonist MERCK & CO INC (US) 1993-05-12 CN disclosed
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed